As treatments for diseases throughout the body progress, treatment for many brain diseases
has been at a standstill due to difficulties in drug delivery. While new drugs are being …

The goal of personalised medicine is to develop tailor-made therapies for patients in whom
currently available therapeutics fail. This approach requires correlating individual patient …

Spinal cord injuries (SCI) cause sensory loss and motor paralysis. They are normally treated
with physical therapy, but most patients fail to recover due to limited neural regeneration …

Glioblastoma Multiforme (GBM) is an aggressive adult primary brain tumor with poor
prognosis. GBM patients develop resistance to the frontline chemotherapy, temozolomide …

The liver is among the principal organs for glucose homeostasis and metabolism. Studies of
liver metabolism are limited by the inability to expand primary hepatocytes in vitro while …

Mesenchymal stromal/stem cells (MSC) have emerged as a class of cells suitable for cellular
delivery of nanoparticles, drugs and micro-RNA cargo for targeted treatments such as tumor …

Mesenchymal stem cells (MSCs) are emerging as candidates for drug delivery to treat
numerous diseases. Their ease of isolation, expansion and reduced ethical concern …

Spinal cord injury (SCI) results in demyelination of surviving axons, loss of oligodendrocytes,
and impairment of motor and sensory functions. We have developed a clinical strategy of …

Spinal cord injury (SCI) is a devastating ailment that results in drastic life style alterations for
the patients and their family members (McDonald and Sadowsky, 2002). Damage post injury …

脊髓损伤是一种破坏性疾病, 会给病患及病人家属的生活方式造成剧烈改变,
长期以来一直被认为是不可逆的, 但细胞疗法的最新研究进展给脊髓损伤带来了希望 …